Detalles de la búsqueda
1.
Phenotypic screening of the ReFRAME drug repurposing library to discover new drugs for treating sickle cell disease.
Proc Natl Acad Sci U S A
; 119(40): e2210779119, 2022 10 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161945
2.
Lovo-cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB-206 study.
Am J Hematol
; 98(1): 11-22, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161320
3.
Optimizing haematopoietic stem and progenitor cell apheresis collection from plerixafor-mobilized patients with sickle cell disease.
Br J Haematol
; 198(4): 740-744, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35737751
4.
Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.
Br J Haematol
; 192(4): 761-768, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33534948
5.
Motivations and Decision-Making of Adult Sickle Cell Patients in High-Risk Clinical Research.
Biol Blood Marrow Transplant
; 26(6): 1225-1232, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32200120
6.
Busulfan Combined with Immunosuppression Allows Efficient Engraftment of Gene-Modified Cells in a Rhesus Macaque Model.
Mol Ther
; 27(9): 1586-1596, 2019 09 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31253582
7.
Kinetic assay shows that increasing red cell volume could be a treatment for sickle cell disease.
Proc Natl Acad Sci U S A
; 114(5): E689-E696, 2017 01 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-28096387
8.
Neurocognitive functioning in symptomatic adults with sickle cell disease: A description and comparison with unaffected siblings.
Neuropsychol Rehabil
; 30(9): 1666-1681, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30924397
9.
Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution.
Biol Blood Marrow Transplant
; 25(3): 577-586, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30342913
10.
Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease - could we strike while the liver is hard?
Br J Haematol
; 187(1): 117-123, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31218662
11.
Natural history of benign ethnic neutropenia in individuals of African ancestry.
Blood Cells Mol Dis
; 77: 12-16, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30909074
12.
At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT.
Blood
; 130(17): 1946-1948, 2017 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-28887325
13.
Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism.
Blood
; 140(23): 2514-2518, 2022 12 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36044658
14.
Ex vivo immunological evaluation of stable mixed chimeric patients after matched related donor allogeneic transplantation in sickle cell disease.
Cytotherapy
; 21(12): 1206-1215, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31784240
15.
Efficient Generation of ß-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease.
Stem Cells
; 35(3): 586-596, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-27739611
16.
Diagnostic challenges of prolonged post-treatment clearance of Plasmodium nucleic acids in a pre-transplant autosplenectomized patient with sickle cell disease.
Malar J
; 17(1): 23, 2018 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29321025
17.
Cardiac effects 2 years after successful non-myeloablative human leukocyte antigen-matched related donor hematopoietic cell transplants in sickle cell disease.
Am J Hematol
; 98(8): E219-E221, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37282828
18.
Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
Int J Mol Sci
; 19(3)2018 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29495591
19.
Oral tetrahydrouridine and decitabine for non-cytotoxic epigenetic gene regulation in sickle cell disease: A randomized phase 1 study.
PLoS Med
; 14(9): e1002382, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28880867
20.
Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease.
Biol Blood Marrow Transplant
; 23(12): 2178-2183, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28882446